Outset Medical (OM) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

OM Stock Forecast


Outset Medical stock forecast is as follows: an average price target of $11.00 (represents a 1673.05% upside from OM’s last price of $0.62) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.

OM Price Target


The average price target for Outset Medical (OM) is $11.00 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $34.00 to $3.00. This represents a potential 1673.05% upside from OM's last price of $0.62.

OM Analyst Ratings


Buy

According to 9 Wall Street analysts, Outset Medical's rating consensus is 'Buy'. The analyst rating breakdown for OM stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 3 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Outset Medical Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 08, 2024Shagun SinghRBC Capital$3.00$3.40-11.76%383.56%
Jun 21, 2024Shagun SinghRBC Capital$6.00$3.5867.36%867.12%
Apr 17, 2024Rick WiseStifel Nicolaus$6.00$2.27164.32%867.12%
Apr 08, 2024Maria ThibaultBTIG$6.00$2.05192.68%867.12%
Apr 05, 2024Kristen StewartC.L. King$6.00$1.94209.28%867.12%
Nov 11, 2022-RBC Capital$23.00$17.5131.35%3607.29%
Aug 03, 2022-Goldman Sachs$34.00$19.4574.76%5380.34%
Jul 18, 2022-Stifel Nicolaus$24.00$16.9141.89%3768.47%
Jun 14, 2022-Stifel Nicolaus$30.00$20.4146.99%4735.59%
Row per page
Go to

The latest Outset Medical stock forecast, released on Aug 08, 2024 by Shagun Singh from RBC Capital, set a price target of $3.00, which represents a -11.76% decrease from the stock price at the time of the forecast ($3.40), and a 383.56% increase from OM last price ($0.62).

Outset Medical Price Target by Period


1M3M12M
# Anlaysts-15
Avg Price Target-$3.00$5.40
Last Closing Price$0.62$0.62$0.62
Upside/Downside-100.00%383.56%770.41%

In the current month, the average price target of Outset Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Outset Medical's last price of $0.62. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 08, 2024Cowen & Co.BuyBuyHold
Aug 08, 2024RBC CapitalOutperformSector PerformDowngrade
Jun 21, 2024RBC CapitalSector PerformOutperformUpgrade
Apr 08, 2024BTIG-BuyInitialise
Aug 17, 2023UBS-NeutralInitialise
Aug 17, 2023RBC CapitalOutperformSector PerformInitialise
Aug 17, 2023BMO Capital-OutperformInitialise
Aug 17, 2023Jefferies-BuyInitialise
Aug 17, 2023Morgan Stanley-Equal-WeightInitialise
Aug 17, 2023Piper Sandler-OverweightInitialise
Row per page
Go to

Outset Medical's last stock rating was published by Cowen & Co. on Aug 08, 2024. The company gave OM a "Buy" rating, the same as its previous rate.

Outset Medical Financial Forecast


Outset Medical Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue-------------$30.36M$36.04M$33.47M$32.01M$27.76M$25.06M$30.55M$28.15M$26.32M$25.22M$22.92M$17.25M$13.76M
Avg Forecast$46.50M$42.73M$40.86M$37.96M$33.87M$32.26M$30.56M$29.28M$27.77M$26.84M$31.17M$30.35M$30.50M$30.39M$34.79M$31.75M$30.92M$25.22M$27.50M$30.11M$26.43M$25.13M$23.73M$21.45M$13.76M$11.53M
High Forecast$46.50M$42.73M$40.86M$37.96M$33.87M$32.26M$30.56M$29.28M$27.77M$26.98M$31.17M$30.35M$30.62M$30.40M$34.79M$31.75M$30.92M$25.22M$27.50M$30.11M$26.43M$25.13M$23.73M$21.45M$13.76M$11.53M
Low Forecast$46.50M$42.73M$40.86M$37.96M$33.87M$32.26M$30.56M$29.28M$27.77M$26.57M$31.17M$30.35M$30.40M$30.35M$34.79M$31.75M$30.92M$25.22M$27.50M$30.11M$26.43M$25.13M$23.73M$21.45M$13.76M$11.53M
# Analysts44443333454136334444333333
Surprise %-------------1.00%1.04%1.05%1.04%1.10%0.91%1.01%1.07%1.05%1.06%1.07%1.25%1.19%

Outset Medical's average Quarter revenue forecast for Dec 23 based on 3 analysts is $30.50M, with a low forecast of $30.40M, and a high forecast of $30.62M. OM's average Quarter revenue forecast represents a 0.45% increase compared to the company's last Quarter revenue of $30.36M (Sep 23).

Outset Medical EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44443333454136334444333333
EBITDA-------------$-45.45M$-43.48M$-40.84M$-37.92M$-40.19M$-43.26M$-35.09M$-40.68M$-28.73M$-28.43M$-28.32M$-29.68M$-41.43M
Avg Forecast$-46.50M$-42.73M$-40.86M$-37.96M$-33.87M$-32.26M$-30.56M$-29.28M$-27.77M$-26.84M$-31.17M$-38.92M$-30.50M$-30.39M$-34.79M$-35.39M$-42.59M$-25.22M$-27.50M$-32.17M$-26.43M$-25.13M$-23.73M$-31.86M$-13.76M$-38.62M
High Forecast$-46.50M$-42.73M$-40.86M$-37.96M$-33.87M$-32.26M$-30.56M$-29.28M$-27.77M$-26.57M$-31.17M$-31.14M$-30.40M$-30.35M$-34.79M$-28.31M$-34.07M$-25.22M$-27.50M$-25.73M$-26.43M$-25.13M$-23.73M$-25.49M$-13.76M$-30.90M
Low Forecast$-46.50M$-42.73M$-40.86M$-37.96M$-33.87M$-32.26M$-30.56M$-29.28M$-27.77M$-26.98M$-31.17M$-46.71M$-30.62M$-30.40M$-34.79M$-42.46M$-51.10M$-25.22M$-27.50M$-38.60M$-26.43M$-25.13M$-23.73M$-38.23M$-13.76M$-46.35M
Surprise %-------------1.50%1.25%1.15%0.89%1.59%1.57%1.09%1.54%1.14%1.20%0.89%2.16%1.07%

undefined analysts predict OM's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Outset Medical's previous annual EBITDA (undefined) of $NaN.

Outset Medical Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44443333454136334444333333
Net Income-------------$-46.18M$-44.05M$-43.97M$-41.44M$-40.78M$-43.84M$-36.89M$-41.23M$-30.47M$-30.21M$-30.02M$-32.04M$-42.29M
Avg Forecast$-14.65M$-15.93M$-17.19M$-18.34M$-17.29M$-18.24M$-18.83M$-19.27M$-20.75M$-22.83M$-23.15M$-40.92M$-33.20M$-36.46M$-39.17M$-37.20M$-43.17M$-38.70M$-33.00M$-33.82M$-36.83M$-36.98M$-35.62M$-33.78M$-34.45M$-39.43M
High Forecast$-14.65M$-15.93M$-17.19M$-18.34M$-17.29M$-18.24M$-18.83M$-19.27M$-20.75M$-20.11M$-23.15M$-32.74M$-29.94M$-31.02M$-39.17M$-29.76M$-34.54M$-38.70M$-33.00M$-27.05M$-36.83M$-36.98M$-35.62M$-27.02M$-34.45M$-31.54M
Low Forecast$-14.65M$-15.93M$-17.19M$-18.34M$-17.29M$-18.24M$-18.83M$-19.27M$-20.75M$-25.00M$-23.15M$-49.10M$-35.92M$-39.19M$-39.17M$-44.64M$-51.80M$-38.70M$-33.00M$-40.58M$-36.83M$-36.98M$-35.62M$-40.53M$-34.45M$-47.31M
Surprise %-------------1.27%1.12%1.18%0.96%1.05%1.33%1.09%1.12%0.82%0.85%0.89%0.93%1.07%

Outset Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OM's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Outset Medical SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44443333454136334444333333
SG&A-------------$36.53M$36.27M$36.12M$33.65M$32.28M$33.98M$30.09M$32.71M$23.36M$22.93M$22.39M$24.25M$26.43M
Avg Forecast$61.83M$56.81M$54.33M$50.47M$45.04M$42.90M$40.64M$38.93M$36.92M$35.69M$41.45M$40.36M$40.56M$40.41M$46.27M$30.34M$41.11M$33.54M$36.56M$27.58M$35.14M$33.41M$31.55M$28.52M$18.30M$15.34M
High Forecast$61.83M$56.81M$54.33M$50.47M$45.04M$42.90M$40.64M$38.93M$36.92M$35.87M$41.45M$40.36M$40.72M$40.43M$46.27M$36.40M$41.11M$33.54M$36.56M$33.09M$35.14M$33.41M$31.55M$28.52M$18.30M$15.34M
Low Forecast$61.83M$56.81M$54.33M$50.47M$45.04M$42.90M$40.64M$38.93M$36.92M$35.33M$41.45M$40.36M$40.42M$40.36M$46.27M$24.27M$41.11M$33.54M$36.56M$22.06M$35.14M$33.41M$31.55M$28.52M$18.30M$15.34M
Surprise %-------------0.90%0.78%1.19%0.82%0.96%0.93%1.09%0.93%0.70%0.73%0.79%1.33%1.72%

Outset Medical's average Quarter SG&A projection for Dec 23 is $40.56M, based on 3 Wall Street analysts, with a range of $40.42M to $40.72M. The forecast indicates a 11.01% rise compared to OM last annual SG&A of $36.53M (Sep 23).

Outset Medical EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44443333454136334444333333
EPS-------------$-0.93$-0.90$-0.90$-0.86$-0.85$-0.92$-0.78$-0.87$-0.65$-0.66$-0.70$-0.75$-3.44
Avg Forecast$-0.28$-0.31$-0.33$-0.35$-0.33$-0.35$-0.36$-0.37$-0.40$-0.44$-0.45$-0.55$-0.64$-0.70$-0.76$-0.73$-0.79$-0.75$-0.64$-0.68$-0.71$-0.71$-0.69$-0.80$-0.66$-2.27
High Forecast$-0.28$-0.31$-0.33$-0.35$-0.33$-0.35$-0.36$-0.37$-0.40$-0.39$-0.45$-0.55$-0.58$-0.60$-0.76$-0.73$-0.79$-0.75$-0.64$-0.68$-0.71$-0.71$-0.69$-0.80$-0.66$-2.27
Low Forecast$-0.28$-0.31$-0.33$-0.35$-0.33$-0.35$-0.36$-0.37$-0.40$-0.48$-0.45$-0.55$-0.69$-0.76$-0.76$-0.73$-0.79$-0.75$-0.64$-0.68$-0.71$-0.71$-0.69$-0.80$-0.66$-2.27
Surprise %-------------1.32%1.19%1.23%1.09%1.14%1.45%1.14%1.23%0.91%0.96%0.87%1.13%1.51%

According to undefined Wall Street analysts, Outset Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OM previous annual EPS of $NaN (undefined).

Outset Medical Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
OMOutset Medical$0.62$11.001674.19%Buy
NVRONevro$5.35$32.72511.59%Hold
SGHTSight Sciences$4.66$10.25119.96%Hold
NPCENeuroPace$6.37$12.88102.20%Buy
OFIXOrthofix Medical$17.33$31.0078.88%-
LUNGPulmonx$7.12$11.9367.56%Buy
SIBNSI-BONE$13.63$20.0046.74%Buy
KIDSOrthoPediatrics$28.74$39.6037.79%Buy
CNMDCONMED$70.47$96.0036.23%Buy
NARIInari Medical$48.93$66.1135.11%Buy
INSPInspire Medical Systems$192.71$238.0023.50%Buy
CVRXCVRx$15.05$16.338.50%Buy
CLPTClearPoint Neuro$12.74$12.00-5.81%Buy
SWAVShockWave Medical$334.75$258.17-22.88%Hold

OM Forecast FAQ


Yes, according to 9 Wall Street analysts, Outset Medical (OM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 66.67% of OM's total ratings.

Outset Medical (OM) average price target is $11 with a range of $3 to $34, implying a 1673.05% from its last price of $0.62. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for OM stock, the company can go up by 1673.05% (from the last price of $0.62 to the average price target of $11), up by 5380.34% based on the highest stock price target, and up by 383.56% based on the lowest stock price target.

OM's average twelve months analyst stock price target of $11 supports the claim that Outset Medical can reach $1 in the near future.

Outset Medical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $125.97M (high $125.97M, low $125.97M), average EBITDA is $-126M (high $-126M, low $-126M), average net income is $-73.633M (high $-73.633M, low $-73.633M), average SG&A $167.51M (high $167.51M, low $167.51M), and average EPS is $-1.419 (high $-1.419, low $-1.419). OM's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $168.04M (high $168.04M, low $168.04M), average EBITDA is $-168M (high $-168M, low $-168M), average net income is $-66.111M (high $-66.111M, low $-66.111M), average SG&A $223.44M (high $223.44M, low $223.44M), and average EPS is $-1.274 (high $-1.274, low $-1.274).

Based on Outset Medical's last annual report (Dec 2022), the company's revenue was $115.38M, beating the average analysts forecast of $113.74M by 1.43%. Apple's EBITDA was $-158M, beating the average prediction of $-127M by 23.73%. The company's net income was $-163M, beating the average estimation of $-149M by 9.60%. Apple's SG&A was $130M, missing the average forecast of $138.79M by -6.34%. Lastly, the company's EPS was $-3.38, beating the average prediction of $-2.852 by 18.51%. In terms of the last quarterly report (Sep 2023), Outset Medical's revenue was $30.36M, missing the average analysts' forecast of $30.39M by -0.10%. The company's EBITDA was $-45.454M, beating the average prediction of $-30.391M by 49.56%. Outset Medical's net income was $-46.18M, beating the average estimation of $-36.464M by 26.64%. The company's SG&A was $36.54M, missing the average forecast of $40.41M by -9.59%. Lastly, the company's EPS was $-0.93, beating the average prediction of $-0.703 by 32.32%